Matthias Peipp PhD

Matthias Peipp is a Head in the Division of Antibody-Based Immunotherapy at the University Hospital Schleswig-Holstein. Matthias is a recognized Key Opinion Leader in the field of bispecific antibodies and immunotherapy, with over 190 publications and 4000 citations. His work is focused on modulating antibody effector functions and strategies to improve recruitment and activation of various immune cell populations (T lymphocytes, NK cells, macrophages). He is one of the collaborators and a Member of the Scientific Advisory Board of BIOMUNEX Pharmaceuticals for immunotherapeutic approaches using bispecific antibodies. Our Scientific Advisory Board is completed by the top Key Opinion Leaders, who are specialists in MAIT cell biology, who were gathered around the unique MAIT engage approach.